Last updated: November 8, 2023
Sponsor: Boston Children's Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Eye Disorders/infections
Vision Loss
Williams Syndrome
Treatment
N/AClinical Study ID
NCT03059420
05-03-036R
R01EY015298
Ages > 1 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- The Engle Lab is very interested in enrolling individuals with congenital conditionsrelated to eye movement, cranial nerve and brainstem-based dysfunction, often broadlyreferred to as congenital cranial dysinnervation disorders (CCDDs).
Exclusion
Exclusion Criteria:
- Individuals with cranial nerve disorders associated with known disorders, such asSaethre-Chotzen associated with established genetic mutations, or acquired conditionsincluding trauma, stroke, tumor or spinal cord injuries.
Study Design
Total Participants: 20000
Study Start date:
February 01, 2004
Estimated Completion Date:
January 31, 2027
Study Description
Connect with a study center
Boston Children's Hospital
Boston, Massachusetts 02115
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.